These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 19349405)
1. An elderly man with rheumatoid arthritis and dyspnea. Nesheiwat JP; Dillon K; McGlothan K; Zaman M; Carbone LD Chest; 2009 Apr; 135(4):1090-1093. PubMed ID: 19349405 [No Abstract] [Full Text] [Related]
2. Leflunomide-related acute interstitial pneumonia in two patients with rheumatoid arthritis: autopsy findings with a mosaic pattern of acute and organizing diffuse alveolar damage. Ochi S; Harigai M; Mizoguchi F; Iwai H; Hagiyama H; Oka T; Miyasaka N Mod Rheumatol; 2006; 16(5):316-20. PubMed ID: 17039315 [TBL] [Abstract][Full Text] [Related]
3. Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review. Keng LT; Lin MW; Huang HN; Chung KP Medicine (Baltimore); 2016 Jun; 95(26):e4044. PubMed ID: 27368035 [TBL] [Abstract][Full Text] [Related]
4. Pulmonary hypertension in a patient with rheumatoid arthritis treated with leflunomide. Martinez-Taboada VM; Rodriguez-Valverde V; Gonzalez-Vilchez F; Armijo JA Rheumatology (Oxford); 2004 Nov; 43(11):1451-3. PubMed ID: 15501999 [No Abstract] [Full Text] [Related]
5. Severe hypertriglygeridemia in a rheumatoid arthritis patient treated with leflunomide. Spanakis EK; Katsikas GA; Sidiropoulos PI; Kritikos HD Clin Exp Rheumatol; 2008; 26(2):382. PubMed ID: 18565269 [No Abstract] [Full Text] [Related]
6. Macrophage activation syndrome after leflunomide treatment in an adult rheumatoid arthritis patient. Ricci M; Rossi P; De Marco G; Varisco V; Marchesoni A Rheumatology (Oxford); 2010 Oct; 49(10):2001. PubMed ID: 20601656 [No Abstract] [Full Text] [Related]
7. Formation of multiple pulmonary nodules during treatment with leflunomide. Yoshikawa GT; Dias GA; Fujihara S; Silva LF; Cruz Lde B; Fuzii HT; Koyama RV J Bras Pneumol; 2015; 41(3):281-4. PubMed ID: 26176527 [TBL] [Abstract][Full Text] [Related]
8. Risk of interstitial lung disease associated with leflunomide treatment in Korean patients with rheumatoid arthritis. Ju JH; Kim SI; Lee JH; Lee SI; Yoo WH; Choe JY; Chung SH; Lee J; Lee YH; Lee SS; Yoon HJ; Yoon CH; Kim HY; Park SH Arthritis Rheum; 2007 Jun; 56(6):2094-6. PubMed ID: 17530652 [No Abstract] [Full Text] [Related]
10. Pulmonary adverse events with leflunomide--myth or reality? Balakrishnan C; Dasgupta B Rheumatology (Oxford); 2007 Feb; 46(2):372; author reply 372-3. PubMed ID: 17158807 [No Abstract] [Full Text] [Related]
11. Severe hepatotoxicity in a rheumatoid arthritis patient switched from leflunomide to methotrexate. Gupta R; Gupta SK MedGenMed; 2005 Sep; 7(3):9. PubMed ID: 16369235 [No Abstract] [Full Text] [Related]
12. Dihydroorotate dehydrogenase polymorphism influences the toxicity of leflunomide treatment in patients with rheumatoid arthritis. Grabar PB; Rozman B; Logar D; Praprotnik S; Dolzan V Ann Rheum Dis; 2009 Aug; 68(8):1367-8. PubMed ID: 19605743 [No Abstract] [Full Text] [Related]
13. Peripheral neuropathy in patients on leflunomide. Bharadwaj A; Haroon N Rheumatology (Oxford); 2004 Jul; 43(7):934. PubMed ID: 15213340 [No Abstract] [Full Text] [Related]